Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Institute of Bioengineering and Nanotechnology (IBN) and IBM Research - Almaden have co-developed biodegradable polymer nanoparticles to combat drug-resistant superbugs, which can selectively eliminate the bacteria without destroying the surrounding healthy red blood cells.
Subscribe to our email newsletter
The biodegradable nanoparticles could be topically applied to the skin or injected into the body to treat MRSA skin infections.
IBM Research – Almaden Advanced Organic Materials scientist James Hedrick said their combined materials development and bioengineering expertise enabled them to discover a new way to potentially treat infectious diseases.
IBN executive director Jackie Ying said this exciting platform technology can make a significant impact on the treatment of multidrug-resistant bacteria.